146 related articles for article (PubMed ID: 8589147)
1. An outbreak of acute fascioliasis among Aymara Indians in the Bolivian Altiplano.
Bjorland J; Bryan RT; Strauss W; Hillyer GV; McAuley JB
Clin Infect Dis; 1995 Nov; 21(5):1228-33. PubMed ID: 8589147
[TBL] [Abstract][Full Text] [Related]
2. Use of the Falcon assay screening test--enzyme-linked immunosorbent assay (FAST-ELISA) and the enzyme-linked immunoelectrotransfer blot (EITB) to determine the prevalence of human fascioliasis in the Bolivian Altiplano.
Hillyer GV; Soler de Galanes M; Rodriguez-Perez J; Bjorland J; Silva de Lagrava M; Ramirez Guzman S; Bryan RT
Am J Trop Med Hyg; 1992 May; 46(5):603-9. PubMed ID: 1599055
[TBL] [Abstract][Full Text] [Related]
3. Immunodiagnosis of Fasciola hepatica infection (fascioliasis) in a human population in the Bolivian Altiplano using purified cathepsin L cysteine proteinase.
O'Neill SM; Parkinson M; Strauss W; Angles R; Dalton JP
Am J Trop Med Hyg; 1998 Apr; 58(4):417-23. PubMed ID: 9574785
[TBL] [Abstract][Full Text] [Related]
4. Presence of very high prevalence and intensity of infection with Fasciola hepatica among Aymara children from the Northern Bolivian Altiplano.
Esteban JG; Flores A; Aguirre C; Strauss W; Angles R; Mas-Coma S
Acta Trop; 1997 Jun; 66(1):1-14. PubMed ID: 9177091
[TBL] [Abstract][Full Text] [Related]
5. Short report: Immunodiagnosis of human fascioliasis using recombinant Fasciola hepatica cathepsin L1 cysteine proteinase.
O'Neill SM; Parkinson M; Dowd AJ; Strauss W; Angles R; Dalton JP
Am J Trop Med Hyg; 1999 May; 60(5):749-51. PubMed ID: 10344647
[TBL] [Abstract][Full Text] [Related]
6. Fascioliasis in relatives of patients with Fasciola hepatica infection in Peru.
Marcos L; Maco V; Terashima A; Samalvides F; Espinoza JR; Gotuzzo E
Rev Inst Med Trop Sao Paulo; 2005; 47(4):219-22. PubMed ID: 16138205
[TBL] [Abstract][Full Text] [Related]
7. Comparative infectivity of Fasciola hepatica metacercariae from isolates of the main and secondary reservoir animal host species in the Bolivian Altiplano high human endemic region.
Valero MA; Mas-Coma S
Folia Parasitol (Praha); 2000; 47(1):17-22. PubMed ID: 10833011
[TBL] [Abstract][Full Text] [Related]
8. [Fasciola hepatica seroprevalence in the Elaziğ region].
Kaplan M; Kuk S; Kalkan A; Demirdağ K; Ozdarendeli A
Mikrobiyol Bul; 2002; 36(3-4):337-42. PubMed ID: 12838669
[TBL] [Abstract][Full Text] [Related]
9. Fasciola hepatica Infection Risk for Adult Household Members Living with Children with Fascioliasis in Cusco, Peru.
Caravedo MA; Ramirez W; Morales ML; Lopez M; Janes CE; Bunag BA; Mixon KL; White AC; Tanabe MB; Cabada MM
Am J Trop Med Hyg; 2021 May; 104(6):2069-2073. PubMed ID: 33939646
[TBL] [Abstract][Full Text] [Related]
10. Seroepidemiology of Fasciola Hepatica in Mersin province and surrounding towns and the role of family history of the Fascioliasis in the transmission of the parasite.
Ozturhan H; Emekdaş G; Sezgin O; Korkmaz M; Altintaş E
Turk J Gastroenterol; 2009 Sep; 20(3):198-203. PubMed ID: 19821202
[TBL] [Abstract][Full Text] [Related]
11. A familial outbreak of fascioliasis in Eastern Anatolia: a report with review of literature.
Karahocagil MK; Akdeniz H; Sunnetcioglu M; Cicek M; Mete R; Akman N; Ceylan E; Karsen H; Yapici K
Acta Trop; 2011 Jun; 118(3):177-83. PubMed ID: 18930014
[TBL] [Abstract][Full Text] [Related]
12. Fascioliasis of livestock and snail host for Fasciola in the Altiplano Region of Bolivia.
Ueno H; Arandia R; Morales G; Medina G
Natl Inst Anim Health Q (Tokyo); 1975; 15(2):61-7. PubMed ID: 1182037
[TBL] [Abstract][Full Text] [Related]
13. The Northern Bolivian Altiplano: a region highly endemic for human fascioliasis.
Mas-Coma S; Anglés R; Esteban JG; Bargues MD; Buchon P; Franken M; Strauss W
Trop Med Int Health; 1999 Jun; 4(6):454-67. PubMed ID: 10444322
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence and Risk Factors of Fascioliasis in Yaks,
Zhang XX; Feng SY; Ma JG; Zheng WB; Yin MY; Qin SY; Zhou DH; Zhao Q; Zhu XQ
Korean J Parasitol; 2017 Feb; 55(1):89-93. PubMed ID: 28285513
[TBL] [Abstract][Full Text] [Related]
15. Serum antibody isotype responses of Fasciola-infected sheep and cattle to excretory and secretory products of Fasciola species.
Phiri IK; Phiri AM; Harrison LJ
Vet Parasitol; 2006 Nov; 141(3-4):234-42. PubMed ID: 16797844
[TBL] [Abstract][Full Text] [Related]
16. Administration of triclabendazole is safe and effective in controlling fascioliasis in an endemic community of the Bolivian Altiplano.
Villegas F; Angles R; Barrientos R; Barrios G; Valero MA; Hamed K; Grueninger H; Ault SK; Montresor A; Engels D; Mas-Coma S; Gabrielli AF
PLoS Negl Trop Dis; 2012; 6(8):e1720. PubMed ID: 22880138
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Fas2-ELISA for the serological detection of Fasciola hepatica infection in humans.
Espinoza JR; Maco V; Marcos L; Saez S; Neyra V; Terashima A; Samalvides F; Gotuzzo E; Chavarry E; Huaman MC; Bargues MD; Valero MA; Mas-Coma S
Am J Trop Med Hyg; 2007 May; 76(5):977-82. PubMed ID: 17488926
[TBL] [Abstract][Full Text] [Related]
18. Mass Drug Administration of Triclabendazole for
Mollinedo S; Gutierrez P; Azurduy R; Valle F; Salas A; Mollinedo Z; Soto P; Villarroel CF; Ransom J; Lawrence R; Berman J; Soto J
Am J Trop Med Hyg; 2019 Jun; 100(6):1494-1497. PubMed ID: 31115295
[TBL] [Abstract][Full Text] [Related]
19. MM3-ELISA evaluation of coproantigen release and serum antibody production in sheep experimentally infected with Fasciola hepatica and F. gigantica.
Valero MA; Ubeira FM; Khoubbane M; Artigas P; Muiño L; Mezo M; Pérez-Crespo I; Periago MV; Mas-Coma S
Vet Parasitol; 2009 Jan; 159(1):77-81. PubMed ID: 19019548
[TBL] [Abstract][Full Text] [Related]
20. Socioeconomic Factors Associated with
Cabada MM; Morales ML; Webb CM; Yang L; Bravenec CA; Lopez M; Bascope R; White AC; Gotuzzo E
Am J Trop Med Hyg; 2018 Nov; 99(5):1180-1185. PubMed ID: 30226136
[No Abstract] [Full Text] [Related]
[Next] [New Search]
